← Open Payments lookup

AGNES KWAPONG-AYEH: Open Payments

NPI 1841676483 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$555 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $529 · 2025 $555

Food & beverage: $555
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Neurocrine BioSciences, Inc.1$97
Luye Pharma (USA) Ltd.1$90
Takeda Pharmaceuticals U.S.A., Inc.2$47
Supernus Pharmaceuticals, Inc.1$18

Products named: REXULTI, CAPLYTA, ERZOFRI EXTENDED-RELEASE, TRINTELLIX, Qelbree.

Industry payments across TX — which companies pay providers there.